Amin Makarem

Stock Analyst at Jefferies

(2.12)
# 3,279
Out of 4,690 analysts
2
Total ratings
100%
Success rate
60.2%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $43.62
Upside: -8.30%
Foghorn Therapeutics
Feb 16, 2026
Maintained: Buy
Price Target: $12
Current: $6.00
Upside: +100.00%